Publications by authors named "Katrin Gysel"

Claim this Profile
R
Real-World Outcomes of Patients With Malignant Pleural Mesothelioma Receiving a Combination of Ipilimumab and Nivolumab as First- or Later-Line Treatment.
Sabine Schmid, Lisa Holer, Katrin Gysel, Kira-Lee Koster, Sacha I Rothschild

JTO Clin Res Rep· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-line durvalumab in patients with PD-L1 positive, advanced non-small cell lung cancer (NSCLC) with a performance status of 2 (PS2). Primary analysis of the multicenter, single-arm phase II trial SAKK 19/17.
Michael Mark, Patrizia Froesch, Katrin Gysel, Sacha I Rothschild, Alfredo Addeo

Eur J Cancer· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metronomic cyclophosphamide for bone marrow carcinomatosis in metastatic castration-resistant prostate cancer.
Tobias Peres, Stefanie Aeppli, Stefanie Fischer, Katrin Gysel, Christian Rothermundt

J Cancer Res Clin Oncol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis